GBA1 and Parkinson disease: The aim of this narrative review is to update and synthesize current knowledge regarding how GBA1 mutations may promote PD and DLB pathogenesis—including both “loss-of-function” and “gain-of-function” mechanisms—and to highlight therapeutic prospects and remaining gaps.